Ashleigh Palmer, President & CEO at UNIGENE LABORATORIES INC (UGNE), bought 10,000 shares at $0.53 ($5K) on 2011-12-21, disclosed to the SEC on 2011-12-22.
Open-market purchase of $5k UGNE by President & CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.53 | 2,500 | $1K | 25.0% |
| 2 | $0.53 | 7,500 | $4K | 75.0% |
| Total | $0.53 avg | 10,000 | $5K | 100% |
| Filing → |
| PRVB | BUY | 2021-12-01 | $25K | — | Filing → |
| PRVB | BUY | 2020-08-18 | $6K | — | Filing → |
| PRVB | BUY | 2020-08-17 | $36K | — | Filing → |